Subversion of host immune responses by otopathogens during otitis media.

Otitis media Pseudomonas aeruginosa chronic suppurative otitis media defensins immune responses otopathogens phase variation

Journal

Journal of leukocyte biology
ISSN: 1938-3673
Titre abrégé: J Leukoc Biol
Pays: England
ID NLM: 8405628

Informations de publication

Date de publication:
10 2019
Historique:
received: 04 01 2019
revised: 11 03 2019
accepted: 05 04 2019
pubmed: 11 5 2019
medline: 27 5 2020
entrez: 11 5 2019
Statut: ppublish

Résumé

Otitis media (OM) is one of the most common ear diseases affecting humans. Children are at greater risk and suffer most frequently from OM, which can cause serious deterioration in the quality of life. OM is generally classified into two main types: acute and chronic OM (AOM and COM). AOM is characterized by tympanic membrane swelling or otorrhea and is accompanied by signs or symptoms of ear infection. In COM, there is a tympanic membrane perforation and purulent discharge. The most common pathogens that cause AOM are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis whereas Pseudomonas aeruginosa and Staphylococcus aureus are commonly associated with COM. Innate and adaptive immune responses provide protection against OM. However, pathogens employ a wide arsenal of weapons to evade potent immune responses and these mechanisms likely contribute to AOM and COM. Immunologic evasion is multifactorial, and involves damage to host mucociliary tract, genetic polymorphisms within otopathogens, the number and variety of different otopathogens in the nasopharynx as well as the interaction between the host's innate and adaptive immune responses. Otopathogens utilize host mucin production, phase variation, biofilm production, glycans, as well as neutrophil and eosinophilic extracellular traps to induce OM. The objective of this review article is to discuss our current understanding about the mechanisms through which otopathogens escape host immunity to induce OM. A better knowledge about the molecular mechanisms leading to subversion of host immune responses will provide novel clues to develop effective treatment modalities for OM.

Identifiants

pubmed: 31075181
doi: 10.1002/JLB.4RU0119-003R
pmc: PMC7166519
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

943-956

Informations de copyright

©2019 Society for Leukocyte Biology.

Références

Immunology. 2010 May;130(1):1-9
pubmed: 20331470
Infect Immun. 2001 Jan;69(1):602-6
pubmed: 11119562
Infect Immun. 2013 Jul;81(7):2606-15
pubmed: 23649097
mSphere. 2017 Jan 18;2(1):
pubmed: 28124027
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8898-903
pubmed: 12855765
Paediatr Respir Rev. 2017 Jan;21:54-61
pubmed: 27424227
J Infect Dis. 2009 Sep 1;200(5):783-93
pubmed: 19642930
Sci Rep. 2016 Nov 02;6:36424
pubmed: 27805043
Otolaryngol Head Neck Surg. 2013 Apr;148(4 Suppl):E64-89
pubmed: 23536533
Ann Otol Rhinol Laryngol. 1996 Dec;105(12):968-74
pubmed: 8973284
PLoS Pathog. 2011 Mar;7(3):e1002012
pubmed: 21483753
Lancet. 2007 Jun 30;369(9580):2196-2210
pubmed: 17604802
Cell. 2014 Dec 4;159(6):1290-9
pubmed: 25480294
Otolaryngol Head Neck Surg. 1999 Nov;121(5):616-21
pubmed: 10547482
BMC Infect Dis. 2006 Jan 24;6:12
pubmed: 16433908
Mol Microbiol. 2017 Aug;105(4):554-571
pubmed: 28557053
J Exp Med. 2008 Jun 9;205(6):1423-34
pubmed: 18504306
Rhinology. 2010 Sep;48(3):312-7
pubmed: 21038022
Pediatr Res. 2010 Sep;68(3):231-6
pubmed: 20531251
DNA Cell Biol. 2009 Aug;28(8):397-403
pubmed: 19435424
FASEB J. 2014 Dec;28(12):5197-207
pubmed: 25183669
BMJ Clin Evid. 2012 Aug 06;2012:
pubmed: 23870746
Infect Immun. 1982 Dec;38(3):1137-48
pubmed: 7152665
Laryngoscope. 2016 Aug;126(8):1946-51
pubmed: 27426942
Am J Respir Cell Mol Biol. 2010 Apr;42(4):450-60
pubmed: 19520922
PLoS One. 2010 Oct 07;5(10):e13224
pubmed: 20949060
Microbiol Spectr. 2015 Aug;3(4):
pubmed: 26350327
Curr Allergy Asthma Rep. 2013 Oct;13(5):495-500
pubmed: 24022464
Front Microbiol. 2016 Nov 18;7:1828
pubmed: 27917157
Hum Immunol. 2014 Aug;75(8):771-6
pubmed: 24882571
Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2741-2747
pubmed: 28466356
Int J Pediatr Otorhinolaryngol. 2002 Oct 21;66(1):1-15
pubmed: 12363416
J Infect Dis. 2016 Sep 1;214(5):817-24
pubmed: 27288538
mBio. 2017 Dec 19;8(6):
pubmed: 29259083
Curr Allergy Asthma Rep. 2011 Dec;11(6):499-507
pubmed: 21901304
Int J Inflam. 2017;2017:4525309
pubmed: 28487811
J Infect Dis. 2012 Apr 15;205(8):1225-9
pubmed: 22383675
Vaccine. 2008 Dec 23;26 Suppl 7:G5-10
pubmed: 19094935
PLoS One. 2013;8(2):e53837
pubmed: 23393551
Immunol Today. 1996 Mar;17(3):138-46
pubmed: 8820272
J Virol. 2006 Feb;80(4):1629-36
pubmed: 16439519
Cell. 2006 Sep 8;126(5):847-50
pubmed: 16959564
BMC Infect Dis. 2004 May 05;4:12
pubmed: 15125783
Biochem Biophys Res Commun. 2004 Nov 19;324(3):1087-94
pubmed: 15485666
Infect Immun. 2009 Sep;77(9):4081-91
pubmed: 19564381
PLoS One. 2007 Oct 10;2(10):e1032
pubmed: 17925880
Microbiologyopen. 2018 Jun;7(3):e00563
pubmed: 29230970
Front Cell Infect Microbiol. 2017 Apr 18;7:125
pubmed: 28459043
Pharm Res. 1994 Jun;11(6):860-4
pubmed: 7937526
Pediatrics. 2007 Oct;120(4):814-23
pubmed: 17908769
Hear Res. 2015 Aug;326:49-58
pubmed: 25922207
Laryngoscope. 2013 Nov;123(11):E66-71
pubmed: 23553435
Biochem Soc Trans. 2011 Aug;39(4):1051-5
pubmed: 21787346
Am J Respir Cell Mol Biol. 2011 Aug;45(2):189-201
pubmed: 21330463
Mol Microbiol. 2015 Apr;96(2):276-92
pubmed: 25597921
Sci Rep. 2017 Jun 9;7(1):3161
pubmed: 28600561
Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16917-22
pubmed: 15546975
JAMA. 2005 Dec 21;294(23):3019-23
pubmed: 16414950
J Biol Chem. 2002 Jan 11;277(2):949-57
pubmed: 11698399
J Immunol. 2013 Oct 15;191(8):4259-68
pubmed: 24048904
Pediatrics. 2013 Mar;131(3):e964-99
pubmed: 23439909
Int J Infect Dis. 2014 Dec;29:259-67
pubmed: 25447732
Pediatr Infect Dis J. 1998 Feb;17(2):149-56
pubmed: 9493813
J Clin Periodontol. 1985 Sep;12(8):648-59
pubmed: 3863838
Infect Genet Evol. 2013 Mar;14:125-36
pubmed: 23266487
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6632-E6641
pubmed: 28696280
Infect Immun. 2003 Oct;71(10):5531-40
pubmed: 14500471
Microbes Infect. 2012 Nov;14(14):1308-18
pubmed: 22975410
Eur Arch Otorhinolaryngol. 2016 Nov;273(11):4003-4009
pubmed: 27234665
J Interferon Cytokine Res. 2007 Aug;27(8):623-36
pubmed: 17784814
Ann Otol Rhinol Laryngol. 1991 Jun;100(6):455-8
pubmed: 2058985
J Infect Dis. 2015 Aug 15;212(4):645-53
pubmed: 25712964
PLoS One. 2016 Apr 14;11(4):e0152865
pubmed: 27078692
Nat Rev Dis Primers. 2016 Sep 08;2:16063
pubmed: 27604644
PLoS One. 2010 Feb 09;5(2):e9098
pubmed: 20161732
J Clin Microbiol. 2011 Apr;49(4):1646-9
pubmed: 21346044
Vaccine. 2013 Jun 26;31(30):3090-7
pubmed: 23632305
Trends Microbiol. 2018 Aug;26(8):727-728
pubmed: 29793827
Curr Allergy Asthma Rep. 2016 Jan;16(1):6
pubmed: 26732809
Front Immunol. 2016 Aug 15;7:311
pubmed: 27574522
Curr Pharm Des. 2007;13(30):3131-9
pubmed: 17979754
Infect Immun. 2014 Jan;82(1):364-70
pubmed: 24191297
Infect Immun. 2017 Mar 23;85(4):
pubmed: 28096183
J Leukoc Biol. 2010 Feb;87(2):213-22
pubmed: 19843575
Infect Immun. 2017 Aug 18;85(9):
pubmed: 28674033
Immunity. 2011 May 27;34(5):637-50
pubmed: 21616434
J Mol Biol. 2013 Dec 13;425(24):4965-80
pubmed: 24095897
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3770-5
pubmed: 20133713
Curr Allergy Asthma Rep. 2017 May;17(5):33
pubmed: 28455742
J Biol Chem. 2008 Sep 19;283(38):26010-5
pubmed: 18621734
Emerg Infect Dis. 2002 Sep;8(9):881-90
pubmed: 12194761
J Innate Immun. 2013;5(1):24-38
pubmed: 22922323
Infect Immun. 2017 Oct 18;85(11):
pubmed: 28847849
Infect Immun. 2007 Feb;75(2):958-65
pubmed: 17130253
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):E5312-20
pubmed: 25422425
Clin Microbiol Infect. 1999 Jun;5(6):364-370
pubmed: 11856281
Crit Rev Microbiol. 2013 Aug;39(3):229-46
pubmed: 22866947
Curr Allergy Asthma Rep. 2011 Feb;11(1):78-84
pubmed: 21049294
Am J Respir Cell Mol Biol. 2017 Apr;56(4):423-431
pubmed: 27854516
Infect Immun. 1978 Sep;21(3):821-9
pubmed: 711336
Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3553-3560
pubmed: 26946303
Dis Model Mech. 2017 Nov 1;10(11):1289-1300
pubmed: 29125825
Microb Pathog. 2008 Sep;45(3):201-6
pubmed: 18619763
Mol Oral Microbiol. 2010 Feb;25(1):15-24
pubmed: 20331791
Front Microbiol. 2017 Feb 20;8:224
pubmed: 28265264
Nat Commun. 2015 Jul 28;6:7828
pubmed: 26215614
Rhinology. 1996 Mar;34(1):2-8
pubmed: 8739859
PLoS One. 2017 Jul 14;12(7):e0180630
pubmed: 28708872
J Leukoc Biol. 2019 Oct;106(4):943-956
pubmed: 31075181
J Allergy Clin Immunol. 2016 Jan;137(1):258-267
pubmed: 26070883
Int J Pediatr Otorhinolaryngol. 2009 Oct;73(10):1417-22
pubmed: 19682756
Biomol Ther (Seoul). 2018 May 1;26(3):242-254
pubmed: 29310427
Pediatrics. 2009 Dec;124(6):1633-41
pubmed: 19933727
JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):990-995
pubmed: 28796849
Mol Microbiol. 2003 May;48(3):737-51
pubmed: 12694618
Am J Rhinol. 2003 Jul-Aug;17(4):209-14
pubmed: 12962190
mBio. 2018 Jul 31;9(4):
pubmed: 30065093
Clin Otolaryngol. 2018 Feb;43(1):55-67
pubmed: 28485112
Infect Immun. 2012 Mar;80(3):1037-49
pubmed: 22215735
Acta Otolaryngol. 2006 Oct;126(10):1040-5
pubmed: 16923707
Microb Pathog. 2010 Oct;49(4):204-10
pubmed: 20576489
Int J Pediatr Otorhinolaryngol. 2005 Oct;69(10):1311-9
pubmed: 15955573
mBio. 2018 Sep 18;9(5):
pubmed: 30228240
mBio. 2017 Jan 24;8(1):
pubmed: 28119471
J Infect Dis. 2014 Oct 15;210(8):1286-95
pubmed: 24755437
Infect Immun. 2014 Nov;82(11):4802-12
pubmed: 25156728
Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S18-20
pubmed: 2648288
J Med Microbiol. 2015 Oct;64(10):1103-1116
pubmed: 26248613
Biochim Biophys Acta. 2002 Jun 12;1590(1-3):41-51
pubmed: 12063167
Microbiol Mol Biol Rev. 2004 Mar;68(1):132-53
pubmed: 15007099
J Clin Microbiol. 2007 Jan;45(1):97-101
pubmed: 17093036
Front Microbiol. 2016 Mar 04;7:255
pubmed: 26973629
J Clin Microbiol. 2007 Aug;45(8):2446-51
pubmed: 17567788
J Infect Dis. 2007 Apr 15;195(8):1194-202
pubmed: 17357058
Infect Immun. 2005 Sep;73(9):5291-300
pubmed: 16113244
JAMA Otolaryngol Head Neck Surg. 2017 Aug 1;143(8):810-817
pubmed: 28594978
Curr Opin Pediatr. 2015 Feb;27(1):110-5
pubmed: 25514574
Curr Allergy Asthma Rep. 2016 Jul;16(8):54
pubmed: 27393701
J Bacteriol. 1940 Oct;40(4):547-58
pubmed: 16560368
J Infect Dis. 1994 Jun;169(6):1265-70
pubmed: 8195602
PLoS One. 2014 Feb 28;9(2):e90505
pubmed: 24587383
Nat Rev Microbiol. 2018 Jul;16(7):440-452
pubmed: 29674747
Pathog Dis. 2013 Nov;69(2):114-26
pubmed: 23913525
Mediators Inflamm. 2004 Apr;13(2):75-88
pubmed: 15203548
Clin Infect Dis. 2008 Mar 15;46(6):815-23
pubmed: 18279042
Allergy. 2000 May;55(5):435-41
pubmed: 10843423
Antimicrob Agents Chemother. 2005 Jul;49(7):2972-8
pubmed: 15980377

Auteurs

James M Parrish (JM)

Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Manasi Soni (M)

Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Rahul Mittal (R)

Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH